_db33a8.png)
.thumb.png.9594b08ba898a6b0d0fa1576ea2c9574.thumb.png.3097220ace298f0faaab6884cd0ea0f5.png)
We are seeking director-led applications to investigate mechanistic biomedical drivers of obesity and related cardiometabolic disease and deliver transformative impact in obesity research.
The director, supported by a leadership team, will lead the design and delivery of a collaborative institute. Applications should focus on the key barriers to unlock understanding of the causes and consequences of obesity to enable targeted prevention and treatment.
The funding available is up to £60 million, and for seven years duration, with the potential to renew.
Funding of this opportunity is subject to approval of a full business case.
This is a pre-announcement and the information may change.
The funding opportunity is expected to open in late July 2026. More information will be available on this page then.